This inventor holds 1 USPTO granted patent. Top assignee: Human Genome Sciences, Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Fazel Khan: Innovator in Wound Healing Therapies
Introduction
Fazel Khan is an accomplished inventor based in Gaithersburg, Maryland, known for his significant contribution to the field of biomedical innovation. His work primarily focuses on groundbreaking therapies aimed at enhancing wound healing, showcasing his commitment to improving patient outcomes through scientific advancements.
Latest Patents
Fazel Khan holds a patent for his invention entitled "Keratinocyte Growth Factor-2 Formulations." This innovative patent covers both liquid and lyophilized forms of Keratinocyte Growth Factor-2 (KGF-2) and its derivatives. The formulation is designed for therapeutic use, particularly to promote and accelerate wound healing, representing a significant advancement in medical treatments.
Career Highlights
Fazel Khan is currently associated with Human Genome Sciences, Inc., where he applies his expertise in biotechnology and pharmaceuticals. His innovative approach to developing KGF-2 formulations demonstrates his dedication to improving healthcare solutions and addressing critical medical needs.
Collaborations
Throughout his career, Fazel has collaborated with notable professionals such as Reiner L Gentz and Arvind Chopra. These partnerships have enabled him to enhance the efficacy of his inventions and contribute to significant advancements within the healthcare landscape.
Conclusion
Fazel Khan is a noteworthy inventor making strides in the medical field, particularly through his work on keratinocyte growth factor formulations. His innovative contributions not only reflect his expertise but also highlight the potential for further advancements in wound healing therapies, paving the way for future research and development in this crucial area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
